(Q37542251)

20 August 2017

1 reference

title

MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients (English)

1 reference

20 August 2017

0 references

1 reference

Elzbieta A Slodkowska

series ordinal

1

1 reference

PubMed ID

19580427

20 August 2017

Jeffrey S Ross

series ordinal

2

1 reference

20 August 2017

1 July 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

5

1 reference

20 August 2017

417-422

1 reference

Commercialized multigene predictors of clinical outcome for breast cancer.

20 August 2017

1 reference

Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.

21 January 2018

1 reference

Breast cancer biomarkers and molecular medicine

21 January 2018

1 reference

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

New generation of molecular prognostic and predictive tests for breast cancer

21 January 2018

1 reference

Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips

21 January 2018

1 reference

Microarrays in breast cancer research and clinical practice--the future lies ahead.

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

21 January 2018

1 reference

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort

21 January 2018

1 reference

Clinical application of the 70-gene profile: the MINDACT trial

21 January 2018

1 reference

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

21 January 2018

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

Trial assessing individualized options for treatment for breast cancer: the TAILORx trial

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies

21 January 2018

1 reference

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.

21 January 2018

1 reference

Is molecular profiling ready for use in clinical decision making?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.09.32

1 reference

20 August 2017

1 reference

PubMed ID

19580427